|
[1]ASRANI SK, LARSON JJ, YAWN B, et al.Underestimation of liver-related mortality in the United States[J].Gastroenterology, 2013, 145 (2) :375-382.
|
|
[2]PISCAGLIA F, MARINELLI S, BOTA S, et al.The role of ultrasound elstographic techniquesin chronic liver disease:Current status and future perspectives[J].Eur J Radiol, 2013, 83 (6) :450-455.
|
|
[3]TANG N, ZHANG Y, LIU Z, et al.Correlation analysis between four serum biomarks of liver fobrosis and liver function in infants with cholestasis[J].Biomed Rep, 2016, 5 (1) :107-112.
|
|
[4]QI X, LI H, CHEN J, et al.Serum liver fibrosis markers for predicting the presence of gastroesophageal varices in liver cirrhosis:A retrospective cross-sectional study[J].Gastroenterol Res Pract, 2015, 2015:274534.
|
|
[5]ZHANG XD, LI WJ, GAO YN, et al.Diagnosis value of serum laminin and hyaluronic acid in liver fibrosis[J].China Med Herald, 2017, 14 (23) :111-113, 121. (in Chinese) 张新弟, 李卫娟, 高娅妮, 等.血清层粘连蛋白、透明质酸诊断肝纤维化的价值[J].中国医药导报, 2017, 14 (23) :111-113, 121.
|
|
[6]QI XS, LIU X, ZHANG Y, et al.Serum liver fibrosis markers in the prognosis of liver cirrhosis:A prospective observational study[J].Med Sci Monit, 2016, 22:2720-2730.
|
|
[7]WAI CT, GREENSON JK, FONTANA RJ, et al.A simple noninvasive index can predict both significant fibrosis ancirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38 (2) :518-526.
|
|
[8]WU FX, GAO BH, NIU CY, et al.Value of aspartate aminotransferase-to-platelet ratio index in diagnosis and prediction of liver fibrosis degree in patients with chronic hepatitis B[J].J Clin Hepatol, 2017, 33 (8) :1483-1486. (in Chinese) 吴方雄, 高保华, 牛春燕, 等.APRI评分对慢性乙型肝炎肝纤维化程度的诊断及预测价值[J].临床肝胆病杂志, 2017, 33 (8) :1483-1486.
|
|
[9]STERLING RK, LISSEN E, CLUMECK N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology, 2006, 43 (6) :1317-1325.
|
|
[10]MA XH, ZHANG X, YOU Y, et al.Diagnostic value of APRIcombined with FIB-4 for significant liver fibrosis in patients with chronic hepatitis B[J].Chin J Gastroenterol, 2017, 22 (9) :544-547. (in Chinese) 马晓辉, 张新, 游云, 等.APRI、FIB-4联合对慢性乙型肝炎患者显著肝纤维化的诊断价值[J].胃肠病学, 2017, 22 (9) :544-547.
|
|
[11]ZHU MY, ZOU X, LI Q, et al.A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis Bvirous infection[J].J Viral Hepat, 2017, 24 (7) :589-598.
|
|
[12]Chinese Society of Hepatology and Chinese Society of Infectious Disease, Chinese Medical Association.The guideline of prevention and trement for chronic hepatitis B:A 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
|
[13]FORNS X, AMPURDANES S, LLOVET JM, et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J].Hepatology, 2002, 36 (4 pt 1) :986-992.
|
|
[14]CALES P, OBERTI F, MICHALAK S, et al.A novel panel of blood markers to assess the degree of liver fibrosis[J].Hepatology, 2005, 42 (6) :1373-1381.
|
|
[15]CHINDAMO MC, BOURSIER J, LUIZ RR, et al.Fibrosis assessment using fibrometer combined to first generation tests in hepatitis C[J].World J Hepatol, 2017, 9 (6) :310-317.
|
|
[16]LEMOINE M, SHIMAKAWA Y, NAYAGAM S, et al.The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa[J].Gut, 2016, 65 (8) :1369-1376.
|
|
[17]HU QG, WANG YQ, GAO YF, et al.The noninvasive diagnostic value of PLT/GGT ratio liver fibrosis in the patients with chronic hepatitis B virous infection[J].Acta Univ Med Anhui, 2017, 52 (10) :1568-1571. (in Chinese) 胡庆刚, 王殷秋, 郜玉峰, 等.PLT/GGT比值对慢性HBV感染者肝纤维化的无创诊断价值[J].安徽医科大学学报, 2017, 52 (10) :1568-1571.
|
|
[18]HUANG CM, YANG Z, NIE YQ, et al.Value of gamma-glutamyl transpeptidas-to-platelet ratio in predicting liver fibrosis stage in chronic hepatitis B patients in Guangdong, China[J].J Clin Hepatol, 2018, 34 (6) :1204-1208. (in Chinese) 黄春明, 杨湛, 聂玉强, 等.GGT/PLT比值对广东地区慢性乙型肝炎患者肝纤维化分期的预测价值[J].临床肝胆病杂志, 2018, 34 (6) :1204-1208.
|
|
[19]GHAFOORY S, VARSHNEY R, ROBISON T, et al.Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury[J].Blood Advances, 2018, 2 (5) :470-480.
|
|
[20]XU AJ, XUE JY, YU SY, et al.The correlation of serm TGF-β1 content with liver fibrosis and Th1/Th2 immune levels in patients with chronic hepatitis B[J].J Hanan Med Coll, 2018, 24 (2) :195-197. (in Chinese) 徐爱静, 薛建亚, 余思雨, 等.慢性乙肝患者血清TGF-β1含量检测及与肝纤维化、Th1/Th2免疫水平的相关关系[J].海南医学院学报, 2018, 24 (2) :195-197.
|
|
[21]LIM JK, FLAMM SL, SINGH S, et al.American Gastroenterological Association Institute guideline on the role of elastography in the evaluation of liver fibrosis[J].Gastroenterology, 2017, 152 (6) :1536-1543.
|
|
[22]RAGAZZO TG, PARANAGUA-VEZOZZO D, LIMA FR, et al.Accuracy of transient elastography-fibrosis, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C[J].Clinics, 2017, 72 (9) :516-525.
|
|
[23]OU XJ, WANG XM, WU XN, et al.Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients[J].Chin J Hepatol, 2015, 23 (2) :103-106. (in Chinese) 欧晓娟, 王晓明, 吴晓宁, 等.FibroTouch与FibroScan在慢性乙型肝炎患者肝纤维化评估中的比较[J].中华肝脏病杂志, 2015, 23 (2) :103-106.
|
|
[24]HERRMANN E, de LEDINGHEN V, CASSINOTTO C, et al.Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography:An individual patient databased meta-analysis[J].Hepatology, 2018, 67 (1) :260-272.
|
|
[25]PAUL SB, DAS P, MAHANTA M, et al.Assessment of liver fibrosis in chronic hepatitis:Comparison of shear wave elastography and transient elastography[J].Abdom Radiol (NY) , 2017, 42 (12) :2864-2873.
|
|
[26]MOUSTAFA EF, MAKHLOUF N, HASSANY SM, et al.Noninvasive assessment of liver fibrosis in patients with hepatic C:Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy[J].Arab J Gastroenterol, 2017, 18 (1) :6-12.
|
|
[27]XIAO G, ZHU S, XIAO X, et al.Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease:Ameta-analysis[J].Hepatology, 2017, 66 (5) :1486-1501.
|
|
[28]SCHMILLEVITCH J, CHAMMAS MC, PUGLIESE V, et al.Acoustic radiation force impulse (ARFI) elastography compared with biopsy for evaluating hepatic fibrosis after liver transplantation:A cross-sectional diagnostic study[J].Sao Paulo Med J, 2016, 134 (6) :513-518.
|
|
[29]MOIL K, ARAI H, ABE T, et al.Spleen stiffness correlates with the presence of ascites but not esophageal varices in chronic hepatitis C patients[J].Biomed Res Int, 2013, 2013:857862.
|
|
[30]WANG M, LIU TT, WANG XM, et al.Comparison of acoustic radiation force impulse and transient electrography for the diagnosis of fibrosis in patients with non-alcoholic fatty liver disease[J].J Clin Exp Med, 2018, 17 (2) :124-128. (in Chinese) 王民, 刘婷婷, 王晓明, 等.评价声辐射力脉冲成像诊断非酒精性脂肪性肝病纤维化的效能[J].临床和实验医学杂志, 2018, 17 (2) :124-128.
|
|
[31]PFEIFER L, ZOPF S, SIEBLER J, et al.Prospective evaluation of acoustic radiation force impulse (ARFI) elastography and highfrequency B-mode ultrasound in compensated patients for the diagnosis of liver fibrosis/cirrhosis in comparison to mini-laparoscopic biopsy[J].Ultraschall Med, 2015, 36 (6) :581-589.
|
|
[32]SHIHA G, SEIF S, ELDESOKY A, et al.A simple bedside blood test (Fibrofast;FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C[J].Hepatol Int, 2017, 11 (3) :286-291.
|
|
[33]TOSON EA, SHINA GE, EL-MEZAYEN HA, et al.Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients:Angiogenic fibrogenic link[J].Eur JGastroenterol Hepatol, 2017, 29 (2) :199-207.
|
|
[34]AHMED HASSAN E, SHARAF EL-DIN ABD EL-REHIM A, AHMED SAYED ZE, et al.VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C[J].Hepatol Res, 2017, 47 (13) :1408-1416.
|
DownLoad: